Abstract
A new series of quinolone-platinum(II) conjugates, [Pt(Q′-NH2)(dmso)X2] and cis-[Pt(Q″-en)X2], where Q′ and Q″ are quinolones (flumequine, nalidixic acid or oxolinic acid) linked to monodentate and bidentate amine ligands, respectively, and X2 is Cl2 or 1,1-cyclobutanedicarboxylate, have been synthesized with the aim of examining the synergetic antitumor activity of quinolone intercalation and platinum(II) chelation. The complexes were characterized by elemental analyses and IR and multinuclear (1H and 195Pt) NMR spectroscopies, and then subjected to in vitro and in vivo bioassays using the leukemia L1210 cell line.
Original language | English |
---|---|
Pages (from-to) | 157-163 |
Number of pages | 7 |
Journal | Journal of Inorganic Biochemistry |
Volume | 87 |
Issue number | 3 |
DOIs | |
State | Published - 2001 |
Bibliographical note
Funding Information:This work was supported financially by the Ministry of Science and Technology and, in part, by the Basic Research Program of the Korea Science and Engineering Foundation.
Keywords
- Antitumor agents
- Platinum
- Quinolone